coming off semaglutide Semaglutide: Half of Users Stop Drug Within Year in 'Concerning' Drop Less than two years after

GLP-1R activation in the hypothalamus and brainstem suppresses appetite via POMC neuron stimulation and NPY/AgRP inhibition, slows gastric emptying, and potentiates glucose-dependent insulin secretion

As this saga unfolds, it will test the interplay of innovation, law, and access in one of the worlds most critical pharmaceutical markets

This approach is essential to objectively demonstrate target engagement and establish a conclusive link to clinical efficacy (Dodson et al., 2019)

These challenges are especially pertinent to GLP-1R-targeted systems, where surface modifications critically influence receptor binding affinity and downstream signaling [550]